Aikenuo

Medical Devices & EquipmentSeries AJiaxing, Chinaaccunome.com.cn

Latest round

Series A

Last raised

Jun 2021

Total raised

Undisclosed

Investors

4

About Aikenuo

Established in 2018 and based in Jiaxing, China, Aikenuo is a biotech company that focuses on the in vitro diagnostic industry. The company engages in the research and development of molecular diagnosis. It has a n real-time PCR. The universal molecular diagnostic platform provides testing services and is used in hospital laboratory and emergency laboratories.

Who invested in Aikenuo

4 investors across 3 rounds

See all investors in Aikenuo

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 3, 2021

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Mar 31, 2020

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Oct 9, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Aikenuo

Who invested in Aikenuo?

Aikenuo has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Aikenuo raised?

Aikenuo has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Aikenuo last raise money?

Aikenuo's most recent round on record is a Series A, in Jun 2021.

What does Aikenuo do?

Established in 2018 and based in Jiaxing, China, Aikenuo is a biotech company that focuses on the in vitro diagnostic industry.

Where is Aikenuo headquartered?

Aikenuo is headquartered in Jiaxing, China.

Which VCs invest in companies like Aikenuo?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Aikenuo's stage. Their profiles are linked below.

Raising like Aikenuo? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.